By: Anushka Sharma
Synopsis Mankind Pharma has launched a Rs 3,000 crore QIP to fund its acquisition of Bharat Serums and Vaccines. The company has seen strong profit growth and significant stock returns.
Anushka Sharma is a sub-editor who writes for CNBC-TV18 and CricTracker, with a focus on national news in India. Her work has been featured in various publications such as The Economic Times, News Karnataka, Sakshi Post, and The Indian Wire. She covers a wide range of topics including politics, business, sports, and entertainment.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
India (National)
Not enough data
Anushka Sharma's coverage primarily focuses on national Indian politics, government policies, and events related to the stock market. Her interest in covering specific political developments and policy decisions suggests she may be interested in receiving pitches related to insightful analysis or expert commentary on significant political events, elections, government policies, and economic matters within India.
Given her focus on government announcements and press releases, it is likely that she would respond well to pitches providing exclusive insights into newsworthy political developments or access to key figures involved in Indian politics. Additionally, considering her occasional coverage of sports like cricket, relevant stories tied to this theme might also capture her attention.
For those seeking media coverage from Anushka Sharma for non-political topics such as the stock market or sports (cricket), it's important that they align their pitch with these interests while also recognizing that national Indian politics remains a top priority for her reporting.
This information evolves through artificial intelligence and human feedback. Improve this profile .